مقاله انگلیسی رایگان در مورد قابلیت اطمینان سرمایه گذاری تحقیق و توسعه – الزویر ۲۰۱۹

elsevier

 

مشخصات مقاله
ترجمه عنوان مقاله قابلیت اطمینان سرمایه گذاری تحقیق و توسعه: شواهدی از زیاندیدگی در گذشته در چین
عنوان انگلیسی مقاله Reliability of R&D capitalization: Evidence from ex post impairment in China
انتشار مقاله سال ۲۰۱۹
تعداد صفحات مقاله انگلیسی ۱۹ صفحه
هزینه دانلود مقاله انگلیسی رایگان میباشد.
پایگاه داده نشریه الزویر
نوع نگارش مقاله
مقاله پژوهشی (Research Article)
مقاله بیس این مقاله بیس میباشد
نمایه (index) Scopus – Master Journals List – DOAJ
نوع مقاله ISI
فرمت مقاله انگلیسی  PDF
ایمپکت فاکتور(IF)
۱٫۶۵۷ در سال ۲۰۱۸
شاخص H_index ۹ در سال ۲۰۱۹
شاخص SJR ۰٫۳۵۸ در سال ۲۰۱۸
شناسه ISSN ۱۷۵۵-۳۰۹۱
شاخص Quartile (چارک) Q3 در سال ۲۰۱۸
مدل مفهومی دارد
پرسشنامه ندارد
متغیر دارد
رفرنس دارد
رشته های مرتبط حسابداری، مدیریت
گرایش های مرتبط حسابداری مالی، مدیریت مالی، سیاست های تحقیق و توسعه، حسابداری مدیریت
نوع ارائه مقاله
ژورنال
مجله  مجله چینی تحقیقات حسابداری – China Journal Of Accounting Research
دانشگاه College of Management and Economics, Tianjin University, China
کلمات کلیدی سرمایه گذاری R&D، قابلیت اطمینان، اختلال، انتخاب حسابداری
کلمات کلیدی انگلیسی R&D capitalization، Reliability، Impairment، Accounting choice
شناسه دیجیتال – doi
https://doi.org/10.1016/j.cjar.2019.08.001
کد محصول E12846
وضعیت ترجمه مقاله  ترجمه آماده این مقاله موجود نمیباشد. میتوانید از طریق دکمه پایین سفارش دهید.
دانلود رایگان مقاله دانلود رایگان مقاله انگلیسی
سفارش ترجمه این مقاله سفارش ترجمه این مقاله

 

فهرست مطالب مقاله:
Abstract

۱- Introduction

۲- R&D accounting in China

۳- Literature review and hypothesis development

۴- Research design

۵- Empirical results

۶- Robustness and additional tests

۷- Conclusion and discussion

References

 

بخشی از متن مقاله:

Abstract

Unlike prior studies that investigate research and development (R&D) accounting as a dichotomous choice between capitalizing vs. expensing, this study identifies low-reliability R&D capitalization by the occurrence of ex post impairment of capitalized R&D costs. I find that low-reliability capitalization is associated with higher discretionary accruals but fails to signal future innovation, whereas normal capitalization without subsequent impairment lacks earnings aggressiveness and predicts future innovation positively, compared to expensing firms. Next, this study shows that Big 4 and industry specialist auditors improve reliability by notably decreasing the likelihood of low-reliability R&D capitalization. The results remain robust after controlling for R&D investment intensity and potential endogeneity in the capitalization decision. Additional tests show that managers strategically time the recognition of impairment for big-bath and earnings-smoothing purposes, and that analyst coverage does not help differentiate between low-reliability and normal R&D capitalization. Collectively, this paper increases our understanding of R&D accounting and auditing and contributes to the debate on the reliability of R&D capitalization.

Introduction

Accounting for corporate research and development (R&D) costs is a controversial issue worldwide. While the International Financial Reporting Standards allow the capitalization of R&D costs when they meet certain criteria, claiming that it conveys relevant information about a firm’s R&D activities, the U.S. Generally Accepted Accounting Principles mandate the full expensing of all R&D costs for public firms (Lev and Sougiannis, 1996), because R&D capitalization, as Healy et al. (2002) emphasize, creates an opportunity for corporate managers to not only discretionarily capitalize the costs of projects that have a low probability of success but also delay the write-down of impaired R&D assets. The lack of real data on R&D capitalization in the U.S. compels researchers to rely on simulation models (e.g. Lev and Sougiannis, 1996; Kothari et al., 2002). As a result, in the debate on relevance vs. reliability in R&D reporting, the reliability side of the trade-off has received far less investigation than relevance. Recently, however, some empirical evidence on the reliability of R&D capitalization has been provided in a few jurisdictions adopting the International Financial Reporting Standards (IFRS). For example, Prencipe et al. (2008) and Markarian et al. (2008) document that companies in Italy tend to use capitalization for earnings-smoothing purposes; Cazavan-Jeny et al. (2011) find that French firms capitalize R&D outlays when they need to meet or beat earnings thresholds; and Xie et al. (2017) find that firms in China are more likely to capitalize R&D costs when the controlling shareholders’ shares are pledged. Overall, these studies suggest that R&D capitalization is driven by management earnings-related incentives and that its reliability is questionable.

ارسال دیدگاه

نشانی ایمیل شما منتشر نخواهد شد.